Kevin Healy

V. Charwat, B. Charrez, B. A. Siemons, H. Finsberg, K. H. Jæger, A. G. Edwards, N. Huebsch, S. Wall, E. Miller, A. Tveito and K. E. Healy

Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System

ACS Pharmacology & Translational Science

Å. Telle, B. Charrez, V. Charwat, H. Finsberg, K. E. Healy and S. Wall

Estimating active tension in cardiac micromuscles

World Congress on Biomechanics (WCB), Taipei, Taiwan (Virtual)

B. Charrez, V. Charwat, B. Siemons, H. Finsberg, E. Miller, A. G. Edwards and K. E. Healy

In vitro safety “clinical trial” of the cardiac liability of drug polytherapy

Clinical and Translational Science

K. H. Jæger, V. Charwat, B. Charrez, H. Finsberg, M. Maleckar, S. Wall, K. E. Healy and A. Tveito

Improved computational identification of drug response using optical measurements of human stem cell derived cardiomyocytes in microphysiological systems

Frontiers in Pharmacology

B. Charrez, V. Charwat, B. Siemons, H. Finsberg, E. Miller, A. G. Edwards and K. E. Healy

In Vitro Safety “Clinical Trial” of the Cardiac Liability of Hydroxychloroquine and Azithromycin as COVID19 Polytherapy

Clinical Pharmacology & Therapeutics

A. Tveito, K. H. Jæger, N. Huebsch, B. Charrez, A. G. Edwards, S. Wall and K. E. Healy

Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems

Nature Scientific Reports